tradingkey.logo

FDA Places Clinical Hold On Sarepta's LGMD Trials - SEC Filing

ReutersJul 21, 2025 11:42 AM

- Sarepta Therapeutics Inc SRPT.O:

  • SAREPTA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SAREPTA'S LGMD TRIALS - SEC FILING

  • SAREPTA THERAPEUTICS INC - HOLD INCLUDES SAREPTA'S SRP-9003, SRP-9004, SRP-6004, SRP-9005 TRIALS - SEC FILING

  • SAREPTA THERAPEUTICS INC - FDA REVOKES DESIGNATION FOR SAREPTA'S AAVRH74 PLATFORM - SEC FILING

  • SAREPTA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SAREPTA'S LGMD TRIALS - SEC FILING

Source text: [ID:n0001193125-25-161516]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI